Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient

Pembrolizumab is an immune checkpoint inhibitor with antitumor activity in other organ malignancies. We present this case —demonstrating multiple inflammatory adverse events associated with Pembrolizumab (in a single patient), in order to increase awareness and facilitate earlier identification of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Honigman, Anthony D., Lai, Francis, Elakis, Joshua, Prall, Owen, Goh, Michelle, McCormack, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452463/
https://www.ncbi.nlm.nih.gov/pubmed/30997084
http://dx.doi.org/10.1002/ccr3.2090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452463/
https://www.ncbi.nlm.nih.gov/pubmed/30997084
http://dx.doi.org/10.1002/ccr3.2090

Ejemplares similares